Cargando…

Febrile Hypotensive Reactions Following ABVD Chemotherapy in Patients With EBV-associated Classical Hodgkin Lymphoma

Detalles Bibliográficos
Autores principales: Bond, David A., Dotson, Emily, Awan, Farrukh T., Baiocchi, Robert A., Blum, Kristie A., Maddocks, Kami
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Inc. 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7104725/
https://www.ncbi.nlm.nih.gov/pubmed/30594446
http://dx.doi.org/10.1016/j.clml.2018.11.020
_version_ 1783512292851187712
author Bond, David A.
Dotson, Emily
Awan, Farrukh T.
Baiocchi, Robert A.
Blum, Kristie A.
Maddocks, Kami
author_facet Bond, David A.
Dotson, Emily
Awan, Farrukh T.
Baiocchi, Robert A.
Blum, Kristie A.
Maddocks, Kami
author_sort Bond, David A.
collection PubMed
description
format Online
Article
Text
id pubmed-7104725
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Elsevier Inc.
record_format MEDLINE/PubMed
spelling pubmed-71047252020-03-31 Febrile Hypotensive Reactions Following ABVD Chemotherapy in Patients With EBV-associated Classical Hodgkin Lymphoma Bond, David A. Dotson, Emily Awan, Farrukh T. Baiocchi, Robert A. Blum, Kristie A. Maddocks, Kami Clin Lymphoma Myeloma Leuk Article Elsevier Inc. 2019-03 2018-11-29 /pmc/articles/PMC7104725/ /pubmed/30594446 http://dx.doi.org/10.1016/j.clml.2018.11.020 Text en © 2018 Elsevier Inc. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Article
Bond, David A.
Dotson, Emily
Awan, Farrukh T.
Baiocchi, Robert A.
Blum, Kristie A.
Maddocks, Kami
Febrile Hypotensive Reactions Following ABVD Chemotherapy in Patients With EBV-associated Classical Hodgkin Lymphoma
title Febrile Hypotensive Reactions Following ABVD Chemotherapy in Patients With EBV-associated Classical Hodgkin Lymphoma
title_full Febrile Hypotensive Reactions Following ABVD Chemotherapy in Patients With EBV-associated Classical Hodgkin Lymphoma
title_fullStr Febrile Hypotensive Reactions Following ABVD Chemotherapy in Patients With EBV-associated Classical Hodgkin Lymphoma
title_full_unstemmed Febrile Hypotensive Reactions Following ABVD Chemotherapy in Patients With EBV-associated Classical Hodgkin Lymphoma
title_short Febrile Hypotensive Reactions Following ABVD Chemotherapy in Patients With EBV-associated Classical Hodgkin Lymphoma
title_sort febrile hypotensive reactions following abvd chemotherapy in patients with ebv-associated classical hodgkin lymphoma
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7104725/
https://www.ncbi.nlm.nih.gov/pubmed/30594446
http://dx.doi.org/10.1016/j.clml.2018.11.020
work_keys_str_mv AT bonddavida febrilehypotensivereactionsfollowingabvdchemotherapyinpatientswithebvassociatedclassicalhodgkinlymphoma
AT dotsonemily febrilehypotensivereactionsfollowingabvdchemotherapyinpatientswithebvassociatedclassicalhodgkinlymphoma
AT awanfarrukht febrilehypotensivereactionsfollowingabvdchemotherapyinpatientswithebvassociatedclassicalhodgkinlymphoma
AT baiocchiroberta febrilehypotensivereactionsfollowingabvdchemotherapyinpatientswithebvassociatedclassicalhodgkinlymphoma
AT blumkristiea febrilehypotensivereactionsfollowingabvdchemotherapyinpatientswithebvassociatedclassicalhodgkinlymphoma
AT maddockskami febrilehypotensivereactionsfollowingabvdchemotherapyinpatientswithebvassociatedclassicalhodgkinlymphoma